Patients who were sedated and intubated during the first wave of COVID-19 recovered and improved—with time and supportive care.
Retail prescription prices drove the costs of drugs for multiple sclerosis to a high of approximmately $85.4 billion in the US.
Greater awareness of sleep disorders has prompted more people to seek treatment. What's changed in 20 years?
See More Videos
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. For information on cookies and how you can disable them visit our Privacy and Cookie Policy.